Εμφάνιση απλής εγγραφής

dc.contributor.author Μεταξά, Αικατερίνη-Φωτεινή el
dc.contributor.author Ευθυμιάδου, Ελένη Κ. el
dc.contributor.author Μπούκος, Νίκος Κ. el
dc.contributor.author Φραγκογιώργη, Ειρήνη Α. el
dc.contributor.author Λούντος, Γεώργιος el
dc.date.accessioned 2015-06-09T19:06:55Z
dc.date.available 2015-06-09T19:06:55Z
dc.date.issued 2015-06-09
dc.identifier.uri http://hdl.handle.net/11400/15615
dc.rights Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/us/ *
dc.source http://www.sciencedirect.com/science/article/pii/S0021979714005451 en
dc.subject Μικροσφαιρίδια
dc.subject Πολυσακχαρίτες
dc.subject Νταουνορουμπικίνη
dc.subject Σύστημα χορήγησης φαρμάκων
dc.subject Φολικό οξύ
dc.subject Microspheres
dc.subject Polysaccharides
dc.subject daunorubicin
dc.subject Drug delivery system
dc.subject Folic acids
dc.title Hollow microspheres based on - folic acid modified - hydroxypropyl Cellulose and synthetic multi-responsive bio-copolymer for targeted cancer therapy en
heal.type journalArticle
heal.secondaryTitle controlled release of daunorubicin, in vitro and in vivo studies en
heal.classification Χημεία
heal.classification Φαρμακευτική
heal.classification Chemistry
heal.classification Pharmacy
heal.classificationURI **N/A**-Χημεία
heal.classificationURI **N/A**-Φαρμακευτική
heal.classificationURI http://skos.um.es/unescothes/C00568
heal.classificationURI http://id.loc.gov/authorities/subjects/sh85100603
heal.keywordURI http://id.loc.gov/authorities/subjects/sh85084923
heal.keywordURI http://id.loc.gov/authorities/subjects/sh85104728
heal.keywordURI http://lod.nal.usda.gov/148792
heal.contributorName Κόρδας, Γεώργιος el
heal.identifier.secondary DOI: 10.1016/j.jcis.2014.08.001
heal.language en
heal.access campus
heal.recordProvider Τεχνολογικό Εκπαιδευτικό Ίδρυμα Αθήνας. Σχολή Τεχνολογικών Εφαρμογών. Τμήμα Μηχανικών Βιοϊατρικής Τεχνολογίας Τ.Ε. el
heal.publicationDate 2014-09-01
heal.bibliographicCitation Metaxa, A.F., Efthimiadou, E.K., Boukos, N., Fragogeorgi, E.A., Loudos, G. et al. (2014) Hollow microspheres based on - Folic acid modified - Hydroxypropyl Cellulose and synthetic multi-responsive bio-copolymer for targeted cancer therapy: Controlled release of daunorubicin, in vitro and in vivo studies. Journal of Colloid and Interface Science. [Online] 435, pp.171-181. Available from: http://www.sciencedirect.com [Accessed 09/06/2015] en
heal.abstract Hypothesis: Conventional chemotherapy drugs such as anthracyclines show no specific activity. They destroy cancer cells but also and the healthy ones, and for that reason exhibit high toxicity. In order to alleviate the toxic effects of chemotherapeutic drugs, the administration dose is being minimized, while their reactivity against tumor cells is lessened. This problem can be overcome or at least reduced by using nanoscale drug delivery systems to target the pathogenic area. The present work deals with the synthesis, characterization and biological evaluation of multi-responsive hollow microspheres coated with Hydroxypropyl Cellulose (HPC)-a biocompatible and thermosensitive polysaccharide-conjugated with folic acid as well promising drug vehicles for targeted cancer therapy. Experiments: The synthetic route consists of two steps. In the first step, a single layer of sensitive copolymers is ((Methacrylic acid (MAA), N-(2-Hydroxypropyl) methacrylamide (HPMA) and N,N'-(disulfanediylbis(ethane-2,1-diyl))bis(2-methylacrylamide) (DSBMA)) fabricated on a sacrificial template of SiO2 and in the second step, an additional layer of the folic acid modified HPC coat the microspheres' surface. The layers fabrication is performed through a combination of distillation precipitation co-polymerization and chemical deposition method. The loading capacity (% LC) and encapsulation efficiency (% EE) percentages of the chemotherapeutic agent daunorubicin (DNR) in the fabricated microspheres were calculated through the standard curve methodology. In addition, the releasing properties of the resulting spheres are investigated, using the above mentioned methodology. It is worth mentioning that, spheres release the entrapped drug under combined conditions such acidic and reductive environment along with conventional hyperthermia. Cytotoxic activity of the synthesized spheres was investigated by using the well-established method of MTT assay in MCF-7 (breast cancer), HeLa (cervical cancer) and HEK 293 (Human Embryonic Kidney healthy cells) cell lines. Confocal and fluorescence microscopy were used to confirm the in vitro targeted ability of folic acid modified drug loaded microspheres in HeLa, to that overexpress folate receptors, MCF-7 and 3T3 cells, as negative folate cell substrate. Finally, radiolabelling of the spheres is performed, with a gamma emitting radionuclide (99mTc), to assess their in vivo profile by means of scintigraphic imaging and biodistribution studies. Findings: Hollow spheres release the encapsulated drug under acidic environment, conventional hyperthermia or in the presence of glutathione (reductive environment). The ability of modified drug carriers to target the HeLa cells, was confirmed by confocal and fluorescence microscopy. The resulting spheres are observed to be promising drug-carriers for cancer treatment due to their releasing properties under tumor's environment and high concentration in HeLa cells via endocytosis. In addition, the empty vehicles have no toxicity in healthy cells and present antimicrobial activity. en
heal.publisher Academic Press Inc. en
heal.journalName Journal of Colloid and Interface Science en
heal.journalType peer-reviewed
heal.fullTextAvailability true


Αρχεία σε αυτό το τεκμήριο

  • Όνομα: 1-s2.0-S0021979714005451-main.pdf
    Μέγεθος: 2.056Mb
    Μορφότυπο: PDF

Οι παρακάτω άδειες σχετίζονται με αυτό το τεκμήριο:

Εμφάνιση απλής εγγραφής

Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες Εκτός από όπου ορίζεται κάτι διαφορετικό, αυτή η άδεια περιγράφεται ως Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες